105 related articles for article (PubMed ID: 22519566)
1. Neuroanatomical correlates of the progressive supranuclear palsy corticobasal syndrome hybrid.
Josephs KA; Eggers SD; Jack CR; Whitwell JL
Eur J Neurol; 2012 Nov; 19(11):1440-6. PubMed ID: 22519566
[TBL] [Abstract][Full Text] [Related]
2. Diffusion tensor imaging comparison of progressive supranuclear palsy and corticobasal syndromes.
Whitwell JL; Schwarz CG; Reid RI; Kantarci K; Jack CR; Josephs KA
Parkinsonism Relat Disord; 2014 May; 20(5):493-8. PubMed ID: 24656943
[TBL] [Abstract][Full Text] [Related]
3. The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy.
Dodich A; Cerami C; Inguscio E; Iannaccone S; Magnani G; Marcone A; Guglielmo P; Vanoli G; Cappa SF; Perani D
Neuroimage Clin; 2019; 24():102009. PubMed ID: 31795064
[TBL] [Abstract][Full Text] [Related]
4. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
[TBL] [Abstract][Full Text] [Related]
5. Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy.
Whitwell JL; Duffy JR; Strand EA; Machulda MM; Senjem ML; Gunter JL; Kantarci K; Eggers SD; Jack CR; Josephs KA
Eur J Neurol; 2013 Apr; 20(4):629-37. PubMed ID: 23078273
[TBL] [Abstract][Full Text] [Related]
6. Imaging correlates of pathology in corticobasal syndrome.
Whitwell JL; Jack CR; Boeve BF; Parisi JE; Ahlskog JE; Drubach DA; Senjem ML; Knopman DS; Petersen RC; Dickson DW; Josephs KA
Neurology; 2010 Nov; 75(21):1879-87. PubMed ID: 21098403
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
[TBL] [Abstract][Full Text] [Related]
8. Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology.
Whitwell JL; Jack CR; Parisi JE; Gunter JL; Weigand SD; Boeve BF; Ahlskog JE; Petersen RC; Dickson DW; Josephs KA
Eur J Neurol; 2013 Oct; 20(10):1417-22. PubMed ID: 23746093
[TBL] [Abstract][Full Text] [Related]
9. Cognitive impairment in progressive supranuclear palsy-Richardson's syndrome is related to white matter damage.
Caso F; Agosta F; Volonté MA; Ferraro PM; Tiraboschi P; Copetti M; Valsasina P; Falautano M; Comi G; Falini A; Filippi M
Parkinsonism Relat Disord; 2016 Oct; 31():65-71. PubMed ID: 27453032
[TBL] [Abstract][Full Text] [Related]
10. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
Sajjadi SA; Acosta-Cabronero J; Patterson K; Diaz-de-Grenu LZ; Williams GB; Nestor PJ
Brain; 2013 Jul; 136(Pt 7):2253-61. PubMed ID: 23729473
[TBL] [Abstract][Full Text] [Related]
11. The pimple sign of progressive supranuclear palsy syndrome.
Botha H; Whitwell JL; Madhaven A; Senjem ML; Lowe V; Josephs KA
Parkinsonism Relat Disord; 2014 Feb; 20(2):180-5. PubMed ID: 24252300
[TBL] [Abstract][Full Text] [Related]
12. The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson's syndrome.
Sakurai K; Imabayashi E; Tokumaru AM; Hasebe S; Murayama S; Morimoto S; Kanemaru K; Takao M; Shibamoto Y; Matsukawa N
Neuroimage Clin; 2015; 7():605-10. PubMed ID: 26082887
[TBL] [Abstract][Full Text] [Related]
13. Voxel-based morphometry in autopsy proven PSP and CBD.
Josephs KA; Whitwell JL; Dickson DW; Boeve BF; Knopman DS; Petersen RC; Parisi JE; Jack CR
Neurobiol Aging; 2008 Feb; 29(2):280-9. PubMed ID: 17097770
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy.
Bruns MB; Josephs KA
Int Rev Psychiatry; 2013 Apr; 25(2):197-209. PubMed ID: 23611349
[TBL] [Abstract][Full Text] [Related]
15. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
[TBL] [Abstract][Full Text] [Related]
16. Modeling trajectories of regional volume loss in progressive supranuclear palsy.
Josephs KA; Xia R; Mandrekar J; Gunter JL; Senjem ML; Jack CR; Whitwell JL
Mov Disord; 2013 Jul; 28(8):1117-24. PubMed ID: 23568852
[TBL] [Abstract][Full Text] [Related]
17. Does corticobasal degeneration exist? A clinicopathological re-evaluation.
Ling H; O'Sullivan SS; Holton JL; Revesz T; Massey LA; Williams DR; Paviour DC; Lees AJ
Brain; 2010 Jul; 133(Pt 7):2045-57. PubMed ID: 20584946
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
Lehéricy S; Hartmann A; Lannuzel A; Galanaud D; Delmaire C; Bienaimée MJ; Jodoin N; Roze E; Gaymard B; Vidailhet M
Brain; 2010 Aug; 133(Pt 8):2410-25. PubMed ID: 20826434
[TBL] [Abstract][Full Text] [Related]
19. Functional disconnection of thalamic and cerebellar dentate nucleus networks in progressive supranuclear palsy and corticobasal syndrome.
Upadhyay N; Suppa A; Piattella MC; Giannì C; Bologna M; Di Stasio F; Petsas N; Tona F; Fabbrini G; Berardelli A; Pantano P
Parkinsonism Relat Disord; 2017 Jun; 39():52-57. PubMed ID: 28318985
[TBL] [Abstract][Full Text] [Related]
20. [The diagnostic challenge of corticobasal degeneration: distinction between clinical syndrome and pathology].
Kellner O; Sabova K; Neumann M; Jung HH
Fortschr Neurol Psychiatr; 2011 Nov; 79(11):660-7. PubMed ID: 22009274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
